Changhee Park
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in
-
- Photodynamic Therapy Research Studies 5
- Lung Cancer Treatments and Mutations 5
- Sarcoma Diagnosis and Treatment 4
- Oncology 15
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Heebeom Koo (10 shared papers)Jihye Yoo (9 shared papers)Gawon Yi (6 shared papers)Dong‐Hyun Lee (4 shared papers)Jihwan Son (6 shared papers)Hak Soo Choi (1 shared paper)Kazunobu Nishimura (7 shared papers)Teruaki AKAMATSU (5 shared papers)
- Journals
- ESMO Open (3 papers)Artificial Organs (3 papers)ASAIO Journal (3 papers)Cancer Research and Treatment (2 papers)Cancers (2 papers)
- Partner nations
- South KoreaJapanUnited States
In The Last Decade
Changhee Park
61 papers receiving 1.5k citations
Changhee Park's Hit Papers
Peers
Comparison fields: 5 of 132
- Biomaterials 427
- Pharmaceutical Science 102
- Biomedical Engineering 627
- Pulmonary and Respiratory Medicine 236
- Molecular Medicine 33
Countries citing papers authored by Changhee Park
This map shows the geographic impact of Changhee Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changhee Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changhee Park more than expected).
Fields of papers citing papers by Changhee Park
This network shows the impact of papers produced by Changhee Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changhee Park. The network helps show where Changhee Park may publish in the future.
Co-authors
The 25 scholars most cited alongside Changhee Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems Hit paper breakdown → | 2019 | 508 |
| 2 | 2018 | 124 | |
| 3 | 2018 | 108 | |
| 4 | 2018 | 89 | |
| 5 | 2012 | 83 | |
| 6 | 1995 | 57 | |
| 7 | 2020 | 46 | |
| 8 | 2018 | 42 | |
| 9 | 2019 | 39 | |
| 10 | 2019 | 35 | |
| 11 | 2020 | 31 | |
| 12 | 2019 | 25 | |
| 13 | 2023 | 20 | |
| 14 | 2020 | 18 | |
| 15 | 2021 | 17 | |
| 16 | 2020 | 16 | |
| 17 | 2023 | 15 | |
| 18 | 2020 | 14 | |
| 19 | 2024 | 13 | |
| 20 | 2019 | 13 |
About Changhee Park
Changhee Park is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Biomedical Engineering, Molecular Biology and Biomaterials, having authored 68 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers), Photodynamic Therapy Research Studies (5 papers), Cancer Genomics and Diagnostics (5 papers), Mechanical Circulatory Support Devices (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Biomaterials (427 citations), Pharmaceutical Science (102 citations), Biomedical Engineering (627 citations), Pulmonary and Respiratory Medicine (236 citations) and Molecular Medicine (33 citations). Changhee Park has collaborated with scholars based in South Korea, Japan and United States. Frequent co-authors include Heebeom Koo, Jihye Yoo, Gawon Yi, Dong‐Hyun Lee, Jihwan Son, Hak Soo Choi, Kazunobu Nishimura, Teruaki AKAMATSU, Tomonori Tsukiya and Cheol‐Ho Lee. Their work appears in journals such as ESMO Open, Artificial Organs, ASAIO Journal, Cancer Research and Treatment and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.